More news
June 2017
Thanks to our collaboration with Vall d’Hebron Institute of Research (VHIR), a dproof of concept of SEFALDIN efficacy in melanoma have been done.
Septembre 2016
Advanced Biodesign have published in Blood Cancer Journal an article outlining the efficacy of the SEFALDIN® treatment in the Acute Myeloide Leukemia.